Ezetimibe and Simvastatin
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease…
Medications Updated During November 2019, From Newest to Oldest, Page 4
Dexmethylphenidate Hydrochloride
Dexmethylphenidate hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)]. Dexmethylphenidate hydrochloride…
Namenda XR (Memantine Hydrochloride)
NAMENDA XR is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. NAMENDA XR is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the…
Triazolam
Triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Triazolam is a benzodiazepine indicated for the short-term treatment of insomnia…
Triamcinolone Acetonide (Triamcinolone Acetonide Ointment USP, 0.05%)
Triamcinolone Acetonide Ointment 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. CONTRAINDICATIONS: Topical…